Legal Representation
Attorney
Damon A. Neagle
USPTO Deadlines
Next Deadline
2117 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-05-20)
Due Date
May 20, 2031
Grace Period Ends
November 20, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 20, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 20, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 25, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 25, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Apr 16, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 16, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Feb 6, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 6, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 5, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 5, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 5, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Feb 5, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Aug 6, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 11, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 11, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 22, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 8, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 7, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 7, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 7, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 7, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 3, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 3, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 3, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 3, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 29, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 28, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 27, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 2, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
providing scientific and medical research information in the field of DNA analysis and clinical trials relating thereto; DNA sequencing technology research; DNA screening for scientific research purposes; DNA analysis services for scientific research purposes; Genetic testing for scientific research purposes; Genetic mapping for scientific purposes; Scientific research in the field of genetics; Providing medical and scientific research information in the fields of pharmaceuticals and genetics
First Use Anywhere:
Dec 1, 2023
First Use in Commerce:
Dec 1, 2023
Class 044
DNA screening for medical purposes; Genetic testing for medical purposes; providing medical information in the field of DNA screening and genetic testing for medical purposes; Providing a web site featuring educational information regarding DNA screening and genetic testing for medical purposes; Genetic counseling
First Use Anywhere:
Dec 1, 2023
First Use in Commerce:
Dec 1, 2023
Additional Information
Design Mark
The mark consists of the word "DNA" in stylized capital letters next to an eight-pointed star with an elongated bottom point above the stylized word "ANSWERS" in lower case letters.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
DEOXYRIBONUCLEIC ACID ANSWERS
Classification
International Classes
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"DNA"